Zeus Detox & Rehab provides residential addiction treatment in Poland with an emphasis on safety, confidentiality, and individualized clinical responsibility. The clinic supports patients with medical detoxification and structured follow-up care, and it offers medication-assisted approaches within comprehensive treatment plans. A key specialty is alcohol use disorder treatment, including naltrexone implantation and disulfiram (“Esperal”) for selected patients. For naltrexone implantation, the procedure is performed by a physician and is always preceded by medical qualification. Implantation takes place under sterile conditions in a confidential clinical setting, and qualification includes a detailed medical history, assessment of previous addiction treatment, exclusion of contraindications, confirmation of abstinence, and discussion of the mechanism of action and treatment limitations. Zeus Detox & Rehab frames naltrexone as a long-acting, physician-performed option rather than a standalone cure. The clinic explains that naltrexone blocks opioid receptors and may reduce or eliminate euphoric effects and help decrease cravings in some patients, while also emphasizing that it does not treat the underlying causes of addiction and does not replace psychotherapy. For disulfiram (“Esperal”), the clinic positions it as an aversive medication used in selected patients; it may support abstinence in specific circumstances but should not be viewed as stand-alone therapy. The clinic also highlights how disulfiram works by triggering a strongly unpleasant physiological reaction after alcohol exposure, which can support avoidance of alcohol particularly during early abstinence. To protect patients, Zeus Detox & Rehab clearly communicates that disulfiram use—including implantation—can involve potential medical risk, that individual response may vary and can be difficult to predict, and that it may include systemic and local adverse effects. The clinic also notes that disulfiram does not guarantee abstinence and does not eliminate relapse risk, and it does not replace psychotherapy or psychiatric treatment. Disulfiram is described as usable only after medical qualification and full informed consent, with patients instructed on the need to strictly avoid alcohol. International patients benefit from a confidential inquiry workflow where messages are delivered directly to the team responsible for treatment coordination. Clinical decisions for medication implants are described as requiring individual medical qualification and physician assessment. For clinical responsibility and oversight, Zeus Detox & Rehab places final accountability for clinical content conformity with current treatment standards on the Medical Director, Andrzej Kulesza.